186 related articles for article (PubMed ID: 17655741)
1. Role of NF2 haploinsufficiency in NF2-associated polyneuropathy.
Hanemann CO; Diebold R; Kaufmann D
Brain Pathol; 2007 Oct; 17(4):371-6. PubMed ID: 17655741
[TBL] [Abstract][Full Text] [Related]
2. Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy.
Schulz A; Baader SL; Niwa-Kawakita M; Jung MJ; Bauer R; Garcia C; Zoch A; Schacke S; Hagel C; Mautner VF; Hanemann CO; Dun XP; Parkinson DB; Weis J; Schröder JM; Gutmann DH; Giovannini M; Morrison H
Nat Neurosci; 2013 Apr; 16(4):426-33. PubMed ID: 23455610
[TBL] [Abstract][Full Text] [Related]
3. Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2.
Stemmer-Rachamimov AO; Ino Y; Lim ZY; Jacoby LB; MacCollin M; Gusella JF; Ramesh V; Louis DN
J Neuropathol Exp Neurol; 1998 Dec; 57(12):1164-7. PubMed ID: 9862639
[TBL] [Abstract][Full Text] [Related]
4. Polyneuropathy in neurofibromatosis 2: clinical findings, molecular genetics and neuropathological alterations in sural nerve biopsy specimens.
Hagel C; Lindenau M; Lamszus K; Kluwe L; Stavrou D; Mautner VF
Acta Neuropathol; 2002 Aug; 104(2):179-87. PubMed ID: 12111361
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis 2 with peripheral neuropathies: Electrophysiological, pathological and genetic studies of a Taiwanese family.
Kuo HC; Chen SR; Jung SM; Wu Chou YH; Huang CC; Chuang WL; Wei KC; Ro LS
Neuropathology; 2010 Oct; 30(5):515-23. PubMed ID: 20113402
[TBL] [Abstract][Full Text] [Related]
6. A neuronal function of the tumor suppressor protein merlin.
Schulz A; Zoch A; Morrison H
Acta Neuropathol Commun; 2014 Jul; 2():82. PubMed ID: 25012216
[TBL] [Abstract][Full Text] [Related]
7. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
Welling DB
Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
[TBL] [Abstract][Full Text] [Related]
8. [A case of neurofibromatosis type 2 (NF2) presenting with late-onset axonal polyneuropathy].
Iseki C; Takahashi Y; Wada M; Kawanami T; Kurita K; Kato T
Rinsho Shinkeigaku; 2009 Jul; 49(7):419-23. PubMed ID: 19715170
[TBL] [Abstract][Full Text] [Related]
9. Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.
Truong K; Ahmad I; Jason Clark J; Seline A; Bertroche T; Mostaert B; Van Daele DJ; Hansen MR
Neuroscience; 2018 Mar; 374():205-213. PubMed ID: 29408605
[TBL] [Abstract][Full Text] [Related]
10. A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation.
Gehlhausen JR; Park SJ; Hickox AE; Shew M; Staser K; Rhodes SD; Menon K; Lajiness JD; Mwanthi M; Yang X; Yuan J; Territo P; Hutchins G; Nalepa G; Yang FC; Conway SJ; Heinz MG; Stemmer-Rachamimov A; Yates CW; Wade Clapp D
Hum Mol Genet; 2015 Jan; 24(1):1-8. PubMed ID: 25113746
[TBL] [Abstract][Full Text] [Related]
11. Molecular biology of vestibular schwannomas.
Chang LS; Welling DB
Methods Mol Biol; 2009; 493():163-77. PubMed ID: 18839347
[TBL] [Abstract][Full Text] [Related]
12. NF2: the wizardry of merlin.
Xiao GH; Chernoff J; Testa JR
Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of SIRT2 in merlin/NF2-mutant Schwann cells triggers necrosis.
Petrilli A; Bott M; Fernández-Valle C
Oncotarget; 2013 Dec; 4(12):2354-65. PubMed ID: 24259290
[TBL] [Abstract][Full Text] [Related]
14. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
[TBL] [Abstract][Full Text] [Related]
15. Generation and Use of Merlin-Deficient Human Schwann Cells for a High-Throughput Chemical Genomics Screening Assay.
Petrilli AM; Fernández-Valle C
Methods Mol Biol; 2018; 1739():161-173. PubMed ID: 29546707
[TBL] [Abstract][Full Text] [Related]
16. Microarray analysis of gene expression in vestibular schwannomas reveals SPP1/MET signaling pathway and androgen receptor deregulation.
Torres-Martin M; Lassaletta L; San-Roman-Montero J; De Campos JM; Isla A; Gavilan J; Melendez B; Pinto GR; Burbano RR; Castresana JS; Rey JA
Int J Oncol; 2013 Mar; 42(3):848-62. PubMed ID: 23354516
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis type 2.
Uppal S; Coatesworth AP
Int J Clin Pract; 2003 Oct; 57(8):698-703. PubMed ID: 14627181
[TBL] [Abstract][Full Text] [Related]
18. PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2).
Hawley E; Gehlhausen J; Karchugina S; Chow HY; Araiza-Olivera D; Radu M; Smith A; Burks C; Jiang L; Li X; Bessler W; Masters A; Edwards D; Burgin C; Jones D; Yates C; Clapp DW; Chernoff J; Park SJ
Hum Mol Genet; 2021 Aug; 30(17):1607-1617. PubMed ID: 34075397
[TBL] [Abstract][Full Text] [Related]
19. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
20. Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis.
Smith MJ; Bowers NL; Bulman M; Gokhale C; Wallace AJ; King AT; Lloyd SK; Rutherford SA; Hammerbeck-Ward CL; Freeman SR; Evans DG
Neurology; 2017 Jan; 88(1):87-92. PubMed ID: 27856782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
